AZD8529 Single Ascending Dose Study - SAD
Study identifier:D1960C00001
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Phase I, Single-Center, Randomized, Double-Blind, Placebo Controlled Single-Ascending Dose, First Time Into Man Study to Assess the Safety, Tolerability, and PK of AZD8529 in Healthy Subjects Part B: A Randomized, Open Label Study to Assess the Effect of Food on AZD 8529
Medical condition
Healthy Volunteer
Phase
Phase 1
Healthy volunteers
Yes
Study drug
AZD8529, Placebo
Sex
All
Actual Enrollment
58
Study type
Interventional
Age
18 Years - 45 Years
Date
Study Start Date: 01 Sept 2008
Primary Completion Date: -
Study Completion Date: 01 Mar 2009
Study design
Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Double Blind
Primary Purpose: Other
Verification:
Verified 01 Mar 2009 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1 | Drug: AZD8529 Oral |
| Placebo Comparator: 2 | Drug: Placebo Oral |
Contacts
Investigators
Principal Investigator
Sylvan J Hurewitz
AstraZeneca Clinical Pharmacology Unit, US
